Shire Share Discussion Threads

[andyj] 24/10/2017 14:15

Waiting for 36.00 here

[philanderer] 24/10/2017 14:01

fozzy, what price are you waiting for ?

[fozzyb] 24/10/2017 12:58

52wk low in sight, a little bit more pls...

[essentialinvestor] 24/10/2017 11:02

Put it back on watch this AM.
Thought it may be volatile in the run up to results as mentioned last week.

Be careful if you are running short term positions on Friday.

[steeplejack] 24/10/2017 10:43

Ridiculous the way these target prices are trimmed as the share price falls.

[philanderer] 24/10/2017 09:34

24th oct Liberum hold tp 4200p cut from 4400p
24th oct Berenberg buy tp 5900p cut from 6000p

[scobak] 23/10/2017 19:10

Just looking at a couple of paragraphs written by James Griffin of Fidelity Money builder fund 'Shire is the cheapest large pharma company in Europe. The market is worried about new competition to the company's haemophilia drugs and its high level of borrowing. However I believe both are overstated.
It is a highly profitable business so I am confident its debt will be paid quickly. There are also a number of exciting products on the way that are being missed amid the doom and gloom such as Xiidra, a totally new product for dry eyes. These could offer significant growth potential area over the coming years.'
This puts the investment case in a nutshell in my mind.

[justiceforthemany] 20/10/2017 21:34

Shire is a high beta 1.5 high volatility share with wild daily swings mostly negative recently. Main reason I can find is concern over debt post Baxalta. What are people's thoughts on this? Justified? $7.4Bn short term liability, $4Bn EBITDA.

[justiceforthemany] 20/10/2017 21:30

Was it not Goldman Sachs who issued a CONVICTION BUY note only 2 days ago? Target price >6000p?!! That is quite a big difference!

[philanderer] 20/10/2017 20:37

I won't be buying any more of these fozzy ;-D

[philanderer] 20/10/2017 20:37

In fact at the moment I'd be happy to wipe my face

[fozzyb] 20/10/2017 19:07

Limit orders at the ready next week

[justiceforthemany] 20/10/2017 17:48

philanderer better week for me all down to Spire which I tipped and rose >10% this week. See it hitting 300p soon.
Portfolio +1.7%
FTSE350 -0.23%
Looked at MERL and RB but P/E's >20. P/E here now just 9.8.

[justiceforthemany] 20/10/2017 17:44

That activist will not be happy will he? Hard to believe this was 3960p Monday. Down 7% in 4 days - like I said just like a volatile miner or AIM share. How 'bemused' is Ornskov now by the share price? Hitting 2014 lows pre-Baxalta. If there is an offer in the mid to high 40's I say sell. Big holders here are BlackRock 6% and Deutsche 3%.

[philanderer] 20/10/2017 17:12

Another poor week for SHP -103p , and a p*ss poor week for the portfolio -1.3% , mainly due to an abysmal trading update from MERL which I duly dumped.

FTSE100 -0.1%
FTSE250 -0.6%

Good weekend everyone. Hang on to your hats by the look of it if you live in the south ;-)

[justiceforthemany] 20/10/2017 15:00

Looking on the bright side sentiment here is now so negative that any positive news/better than expected Q3 results next Friday could see a 10% rise. Could see some developments over the weekend also re: sale or spin off.

[romeike] 20/10/2017 14:33

You think companies like Shire don't exchange currency selective and hedge currencies. This whole over-obsession with currency is farcical. What matters are quarterly results.

[philanderer] 20/10/2017 09:27

Normal service resumed this morning.

At least the dividend's been paid into my account , just about covers a couple of Dominos Pizzas ;-)

[philanderer] 19/10/2017 14:45

FBR Capital initiates coverage on Shire plc - American Depositary Shares, each representing three Ordinary Shares (NASDAQ:SHPG) with a Buy rating and a $201.00 price target.


Currently $148.39

[andyj] 19/10/2017 12:19

Whilst we may think they are hugely under rated, watch the intraday chart and note the savage sell offs that occur when the US opens. Definitely not one to buy in the mornings!

[justiceforthemany] 19/10/2017 10:48

Now trading not far off its book price of £34.50. Yes a lot of intangibles/goodwill on the balance sheet post-baxalta but surprisingly it is a similar amount to both GSK and AZN. GSK trades at 15x book price.

[toffeeman] 19/10/2017 08:52

So it seems - although they never include a timescale :)

[essentialinvestor] 19/10/2017 07:24

Glaxo, Glaxo Wellcome, Glaxo SmithKline, GSK.

[ruethewhirl] 19/10/2017 07:08

Why do I have a feeling our mettle will be sorely tested over the next week.